Skip to content
PIL Logo

Elleste Duet Conti

Last Updated on eMC 09-May-2016 View document  | Meda Pharmaceuticals Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 09-May-2016 and displayed until Current

Reasons for adding or updating:

  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - date of revision

Updated on 05-Aug-2015 and displayed until 09-May-2016

Reasons for adding or updating:

  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - use in children/adolescents
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - driving and using machines
  • Change to section 2 - excipient warnings
  • Change to section 6 - date of revision

Updated on 17-Jun-2014 and displayed until 05-Aug-2015

Reasons for adding or updating:

  • Change to section 4 - how to report a side effect

Updated on 04-Jun-2013 and displayed until 17-Jun-2014

Reasons for adding or updating:

  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - driving and using machines
  • Change to section 2 - excipient warnings
  • Change to section 3 - how to take/use
  • Change to section 4 - possible side effects
  • Change to section 6 - what the product contains
  • Change to section 6 - what the product looks like and pack contents

Updated on 04-Dec-2009 and displayed until 04-Jun-2013

Reasons for adding or updating:

  • Change due to harmonisation of PIL.

Updated on 24-Nov-2008 and displayed until 04-Dec-2009

Reasons for adding or updating:

  • Change due to user-testing of patient information

Updated on 23-Oct-2008 and displayed until 24-Nov-2008

Reasons for adding or updating:

  • Change to name of manufacturer

Updated on 07-Jul-2008 and displayed until 23-Oct-2008

Reasons for adding or updating:

  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Company contact details

Meda Pharmaceuticals

Company image
Address

Sky Way House, Parsonage Road, Takeley, Bishop's Stortford, CM22 6PU

Fax

0845 460 0002

Medical Information e-mail
Out of Hours contact

+44 (0)1748 828 810

Telephone

0845 460 0000

Medical Information Direct Line

+44 (0)1748 828 810

Medical Information Fax

+44 (0)1748 828 801

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

estradiol hemihydrate, norethisterone acetate

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue